DESAI VEERAL (Chief Strategy & Dev. Officer) sold 27.7% of their position (106.36K shares) of AGILON HEALTH, INC. on the open market
Open‑market sale worth $2.39M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/28/2022ACC: 0001209191-22-039598
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
-106.36K
Net shares
Net seller
$2.39M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
106.36K acquired · 212.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+106.36K
Price / share
$1.00
Trade value
$106.36K
% of position
38.2%
6/24/2022
278.21K→384.57K
Common Stock
Direct
Shares
−106.36K
Price / share
$22.50
Trade value
$2.39M
% of position
27.7%
6/24/2022
384.57K→278.21K
Total
Net shares
+0.00
Net value
-$2.29M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/24/2022 | M · Option Exercise | +106.36K | $1.00 | $106.36K | 38.2% | 278.21K | 384.57K |
| Common Stock Direct | 6/24/2022 | S · Sale | −106.36K | $22.50 | $2.39M | 27.7% | 384.57K | 278.21K |
| Total | +0.00 | -$2.29M | ||||||
Derivative Transactions1
Options (Rights to Buy)
Direct
Converts to
Common Stock
106.36K shares
Shares
−106.36K
Strike price
1.00
Held after
456.28K
Exercisable
—
6/24/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Rights to Buy) Direct | Common Stock106.36K shares | 6/24/2022 | M · Option Exercise | −106.36K | 1.00 | — | 456.28K |